Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction
Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the <span style="font-variant:small-caps;">VICTOR</span> trial
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF
